PULSES ELECTROMAGNETIC FIELDS

Pre-clinical studies have shown that PEMFs with specific physical signal parameters (I-ONE therapy, IGEA, Carpi, Italy) when used in vitro favor the proliferation of chondrocytes and stimulate proteoglycan synthesis.

In vivo, I-ONE therapy prevents degeneration of articular cartilage and down-regulate the synthesis and release of pro-inflammatory cytokines in the synovial fluid. In a recent clinical study we have demonstrated that I-ONE therapy is an effective chondroprotective treatment for patients without any negative side effects, that it limits inflammation and preserves healthy articular cartilage in the knee.

OUR RESULTS